Latest Research & News

Weiss Ultimate Portfolio Subscription Your Issue
Join Gavin Magor LIVE November 19 for a look inside The Weiss Ultimate Portfolio.
Buried in Anthropic’s IPO roadshow presentation could be a bigger problem for Nvidia than the scandal.
Trump Jr. and Kalshi just parted ways. But the bigger story is the Nov. 18 CFTC deadline, and a way to use prediction market odds without placing a bet.
Key Takeaways With high-grade silver veins, Pacifica Silver should be on your radar. Sean Brodrick sits down with CEO Todd Anthony. This junior miner has big-pocketed backers.   ...
That didn’t stop us from filling your inbox — once you can open it — with expert advice.
Weiss Partners Circle Subscription Your Issue
Plus a 220% combined win and six new ideas.
Each has strong finances, little debt and a big lead on the S&P 500 this past month. Here’s the full list.
What I thought was an 80-day correction may actually be a longer cycle downturn. Here’s how that changes my outlook through 2026 … and what stays the same.
AbbVie earns about three-quarters of its sales at home, so a strong dollar barely dents it. Our target points to about 6% upside, plus a 2.5% dividend.
Plus, a personal invitation to my fireside chat on Thursday, Nov. 19, at 2 p.m. Eastern.
Top Cryptocurrencies
See All »
B
BTC $65,174.00
B
Top Tech Stocks
See All »
B
AAPL NASDAQ $351.91
B
MSFT NASDAQ $506.24
B
NVDA NASDAQ $155.46
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $127.52
B
Top Financial Stocks
See All »
A
A
JPM NYSE $329.96
B
V NYSE $416.77
Top Energy Stocks
See All »
B
CVX NYSE $216.13
B
COP NYSE $139.48
Top Health Care Stocks
See All »
B
LLY NYSE $1,415.55
B
JNJ NYSE $278.70
B
ABBV NYSE $292.82
Top Real Estate Stocks
See All »
B
PLD NYSE $125.56